IQVIA Holdings Inc. (IQV) Free Cash Flow (FCF): $2.05B
The free cash flow (FCF) for IQVIA Holdings Inc. (IQV) is $2.05B. It is below its 12-month average by 1.51% ($2.08B).
IQV Free Cash Flow (FCF) Chart
IQV Average Free Cash Flow (FCF) Chart
IQV Current vs Average Free Cash Flow (FCF) Chart
IQV Free Cash Flow (FCF) Metrics
FREE CASH FLOW (FCF)
$2.05B
FREE CASH FLOW (FCF) AVG TTM
$2.08B
FREE CASH FLOW (FCF) AVG 3Y
$1.81B
FREE CASH FLOW (FCF) AVG 5Y
$1.82B
FREE CASH FLOW (FCF) AVG 10Y
$1.29B
FREE CASH FLOW (FCF) AVG 15Y
$970.12M
FREE CASH FLOW (FCF) AVG 20Y
$970.12M
CURRENT VS TTM AVG
-1.51%
CURRENT VS 3Y AVG
+13.14%
CURRENT VS 5Y AVG
+12.94%
CURRENT VS 10Y AVG
+58.65%
CURRENT VS 15Y AVG
+111.42%
CURRENT VS 20Y AVG
+111.42%
FCF Analysis
Free Cash Flow (TTM)
$2.05B
FCF Yield
8.58%
Price/FCF
11.7
Formula: FCF = Operating Cash Flow - Capital Expenditures
Why FCF matters:
- Shows actual cash available (not accounting earnings)
- Funds dividends, buybacks, and debt reduction
- Less susceptible to accounting manipulation than net income
- Key metric for DCF valuation models
IQVIA Holdings Inc. Free Cash Flow (FCF) Formula & Definition
Free Cash Flow represents the cash a company generates after accounting for capital expenditures. It's the cash available for dividends, buybacks, debt reduction, or reinvestment.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
IQVIA Holdings Inc. Free Cash Flow (FCF) FAQ
- What is the free cash flow (FCF) for IQVIA Holdings Inc. (IQV)?
- The free cash flow (FCF) for IQV stock is $2.05B.
- What is the TTM average free cash flow (FCF) for IQVIA Holdings Inc. (IQV)?
- The TTM average free cash flow (FCF) for IQV stock is $2.08B.
- What is the 3Y average free cash flow (FCF) for IQVIA Holdings Inc. (IQV)?
- The 3Y average free cash flow (FCF) for IQV stock is $1.81B.
- What is the 5Y average free cash flow (FCF) for IQVIA Holdings Inc. (IQV)?
- The 5Y average free cash flow (FCF) for IQV stock is $1.82B.
- What is the 10Y average free cash flow (FCF) for IQVIA Holdings Inc. (IQV)?
- The 10Y average free cash flow (FCF) for IQV stock is $1.29B.
- What is the 15Y average free cash flow (FCF) for IQVIA Holdings Inc. (IQV)?
- The 15Y average free cash flow (FCF) for IQV stock is $970.12M.
- What is the 20Y average free cash flow (FCF) for IQVIA Holdings Inc. (IQV)?
- The 20Y average free cash flow (FCF) for IQV stock is $970.12M.
IQVIA Holdings Inc. Free Cash Flow (FCF) History
| DATE | FREE CASH FLOW (FCF) |
|---|---|
| 2025-12-31 | $2.05B |
| 2024-12-31 | $2.11B |
| 2023-12-31 | $1.50B |
| 2022-12-31 | $1.59B |
| 2021-12-31 | $2.30B |
| 2020-12-31 | $1.34B |
| 2019-12-31 | $835.00M |
| 2018-12-31 | $795.00M |
| 2017-12-31 | $601.00M |
| 2016-12-31 | $696.00M |
| 2015-12-31 | $397.30M |
| 2014-12-31 | $349.10M |
| 2013-12-31 | $305.02M |
| 2012-12-31 | $264.37M |
| 2011-12-31 | $85.27M |
| 2010-12-31 | $297.92M |
Related Metrics
About IQVIA Holdings Inc.
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Ari Bousbib